Cardinal Health Q4 non-GAAP EPS $1.55 (+48%); raises FY24 guidance to $6.50-$6.75

CARDINAL HEALTH INC

2023-FY EPS reported $1.00 revenue$205,012,000,000

Q4 revenue $53.5B (+13% YoY); non-GAAP EPS $1.55 (+48%) vs $1.05 prior year.
Pharmaceutical segment profit up 12% to $504M; Medical segment profit improved to $82M from -$16M.
Full-year non-GAAP EPS $5.79 (+14%), an all-time high; operating cash flow $2.8B.
FY2024 non-GAAP EPS guidance raised to $6.50-$6.75 from $6.45-$6.70; segment profit growth expected.
Director Carrie S. Cox will not stand for re-election at 2023 annual meeting; no disagreement.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Carrie S. Cox

Director

CAH · CARDINAL HEALTH INC

Filed: August 15, 2023, 7:59 PM ET

On August 10, 2023, Carrie S. Cox, a member of the Board of Directors (the “Board”) of the Company since 2009, informed the Company that she has decided not to stand for re-election to the Board when her term expires at the 2023 annual meeting of shareholders.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CARDINAL HEALTH INC reported the quarter and fiscal year ended June 30, 2023 results: revenue $205.0 billion, net income $261 million, EPS $1.00. Guidance raised.

Period: the quarter and fiscal year ended June 30, 2023
Revenue: $205.0 billion
Net income: $261 million
EPS: $1.00
Guidance: raised
Result: reported results

Exact text from the filing

RELEASE Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance • Fourth quarter revenue increased 13% to $53.5 billion • Fourth quarter GAAP 1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 • Fourth quarter non-GAAP operating earnings increased 24% to $560 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CARDINAL HEALTH INC reported the quarter and fiscal year ended June 30, 2023 results: revenue $205.0 billion, net income $261 million, EPS $1.00. Guidance raised.

Period: the quarter and fiscal year ended June 30, 2023
Revenue: $205.0 billion
Net income: $261 million
EPS: $1.00
Guidance: raised
Result: reported results

Exact text from the filing

Fiscal year 2023 revenues were $205.0 billion

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Carrie S. Cox departed as Director at CARDINAL HEALTH INC.

Action: decided not to stand for re-election
Role: Director

Exact text from the filing

On August 10, 2023, Carrie S. Cox, a member of the Board of Directors (the “Board”) of the Company since 2009, informed the Company that she has decided not to stand for re-election to the Board when her term expires at the 2023 annual meeting of shareholders.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

CARDINAL HEALTH INC filing history →

Source: SEC EDGAR

accession 0000721371-23-000058

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.